NFKB1 and metabolic disease: We selected and analysed 20 miRNAs involved in inflammation and metabolic diseases such as NAFLD and atherosclerosis, from that screening we selected and further study four miRNAs, miR‐9‐5p, miR‐15a‐5p, miR‐16‐5p and miR‐199a‐3p that were involved in NF‐κB pathway.